
The companies aim to develop next-generation oral medicines for obesity and diabetes

The companies are working together on cellular medicines to boost, replace or repair biological functions

Approximately 125 million people globally are living with some form of psoriasis

An estimated 84,870 people will be diagnosed with bladder cancer in the US this year

The company is planning to submit regulatory applications for the candidate by the end of the year

The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study

More than 2.5 million people in Europe are living with the inflammatory bowel disease

Approximately 25% of cases are diagnosed during childhood or adolescence

Inflammatory bowel disease is estimated to affect nearly two million people across Europe

The regimen was approved by the MHRA earlier this month to treat EGFR-mutated NSCLC

The commitment marks a 25% increase to the company's US investments in the past four years

An estimated three million people in the US are affected by inflammatory bowel disease